merged_drug-prices-medicare.txt
<question_number>1</question_number>
<answer>The $2,000 annual cap on patient costs for drugs taken at home will go into effect next year, while the new negotiated prices will take effect in 2026.</answer>

<question_number>2</question_number>
<answer>The article suggests that the number of drugs negotiated by the federal government is set to increase in the coming years, and that the drug price negotiation program could be repealed if former President Donald J. Trump wins the White House in November, particularly with full Republican control of Congress.</answer>

<question_number>3</question_number>
<answer>Vice President Kamala Harris cast the tiebreaking vote for the legislation that delivered the drug price negotiation program, which she and President Biden highlighted at the Maryland event. The article also states that Harris has focused some of her early presidential campaign on the Biden administration's drug pricing reforms, including the cap on monthly insulin costs for Medicare recipients.</answer>

<question_number>4</question_number>
<answer>Eliquis, with a 22% reduction in Medicare spending.</answer>

<question_number>5</question_number>
<answer>$730</answer>

<question_number>6</question_number>
<answer>Imbruvica, from AbbVie and Johnson & Johnson.</answer>

<question_number>7</question_number>
<answer>Fiasp and NovoLog insulin products, from Novo Nordisk, at $119 per month.</answer>

<question_number>8</question_number>
<answer>75.5%</answer>

<question_number>9</question_number>
<answer>$19</answer>

<question_number>10</question_number>
<answer>$12,811</answer>